Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors

Zhijia Xia; Shi Chen; Miao He; Benhua Li; Yayuan Deng; Lin Yi; Xiaosong Li

doi:10.3389/fimmu.2023.1247178

Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors

Front Immunol. 2023 Jul 27:14:1247178. doi: 10.3389/fimmu.2023.1247178. eCollection 2023.

Authors

Zhijia Xia¹, Shi Chen², Miao He³, Benhua Li², Yayuan Deng², Lin Yi², Xiaosong Li^{2

4}

Affiliations

¹ Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.
² Clinical Molecular Medicine Testing Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
³ Laboratory Animal Center, Chongqing Medical University, Chongqing, China.
⁴ Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Institute for Brain Science and Disease, Chongqing Medical University, Chongqing, China.

No abstract available

Keywords: T cells; checkpoint blockade; immunotherapy; metabolism; solid tumors.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immune Checkpoint Inhibitors / therapeutic use
Immunotherapy
Neoplasms* / therapy
T-Lymphocytes*

Substances

Immune Checkpoint Inhibitors

Grants and funding

XL was supported by the Chongqing Science and Health Joint Medical High-end Talent Project (No. 2022GDRC012), the Science and Technology Research Program of Chongqing Municipal Education Commission (No. KJZD-K202100402), and the CQMU Program for Youth Innovation in Future Medicine (No. W0073).